VERU (NASDAQ CM) Last Trade: 4.25 Date: February 26, 2020 4:00 pm Change: 0.00
February 26, 2020
Veru Initiates Phase 2 Clinical Trial of VERU-111, First-in-Class, Oral, Advanced Prostate Cancer Drug
February 12, 2020
Veru Continues Strong Positive Sales Momentum in Fiscal 2020 First Quarter; Net Revenues Increase 66%, Gross Profit Up 57%
2019 Cantor Fitzgerald Global Healthcare Conference October 2, 2019
(View Slide Deck)
Listen to other presentations and conference calls
February 24, 2020
Statement of changes in beneficial ownership of securities
February 21, 2020
